GLP-1 TV · Patient story · views checked Oct 2026
🛑STARTING MOUNJARO/ZEPBOUND🛑 2.5 mg dose what to expect the first month!
Patient story
Our summary
Brittany, a creator who says she has lost 83 lbs on Mounjaro (tirzepatide) since November 2022, explains what she thinks new users should expect from the 2.5 mg starter dose. She says interest in Mounjaro and Zepbound has grown sharply, helped by media coverage and an Oprah episode, and that many newcomers do not know what the first month looks like. She notes she has not taken Ozempic or Wegovy, so she focuses on Mounjaro and Zepbound.
One person's experience, in their words. Not medical advice.
Where Zepbound costs least today
The three cheapest partner programs for Zepbound, all in per month, checked weekly. Brand Zepbound and compounded versions are different products; each row says which it is.
What else the video covers
She says 2.5 mg is the starting dose for almost everyone, and that it is a builder dose meant to let the body adjust and keep side effects low, not a therapeutic dose. In her account, the first therapeutic dose is 5 mg. She says she often sees people in a Facebook group worry that they have lost no weight after a month, and she suggests some doctors do not set clear expectations. She says her own doctor also prescribed phentermine at the start to cover the gap until the appetite effect built up. Citing statistics, she says the typical first-month loss is about 2% of body weight, which she puts at no more than about 10 lbs for someone weighing 250 to 300 lbs, and often just a couple of pounds.
She says side effects at 2.5 mg should be mild, such as a little constipation, nausea or trouble sleeping, and that severe stomach pain or constipation is a reason to contact a doctor. She adds that users should still track calories and aim for high protein and high fiber, and she advises against getting caught up in online trends. Her basic advice is to hit protein goals, eat plenty of fiber, drink water and take the shot. The last minutes cover channel updates, including a possible Facebook group.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 2:00 Brittany says 99% of people start on 2.5 mg of tirzepatide, with a few switching from Ozempic starting higher.
- 3:03 She describes 2.5 mg as a builder dose rather than a therapeutic dose, with 5 mg as the first therapeutic dose.
- 4:36 She says her doctor paired her 2.5 mg start with phentermine until the appetite effect built up.
- 5:40 She cites about 2% of body weight as the typical first-month loss, often just a couple of pounds.
- 6:41 She says side effects at 2.5 mg should be mild, and severe pain or constipation warrants a call to a doctor.
- 8:12 She says users should still count calories and eat high protein and high fiber, and avoid getting caught up in online fads.
Key moments
From the creator's own chapters. Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Zepbound and Mounjaro
- Doses mentioned
- 2.5 mg and 5 mg
- Point in the journey
- Month 1
- Side effects mentioned
- constipation and low appetite
- Who is speaking
- Patient
Questions this video answers
How much weight can you lose in the first month on Mounjaro 2.5 mg?
Brittany says statistics show about 2% of body weight in the first month. She puts that at no more than about 10 lbs for someone around 250 to 300 lbs, and often just a couple of pounds.
Is 2.5 mg of Mounjaro or Zepbound a therapeutic dose?
According to Brittany, no. She describes 2.5 mg as a starter or builder dose that lets the body adjust and limits side effects, and says the first therapeutic dose is 5 mg.
What side effects should you expect on the Mounjaro starter dose?
She says side effects should be mild, such as a little constipation, nausea or trouble sleeping. She says severe stomach pain or very bad constipation is not normal and should be raised with a doctor.
Will appetite suppression be strong on 2.5 mg of tirzepatide?
Brittany says most people feel some appetite suppression in the first month, but it is not very strong yet. She says users should still plan to count calories and eat high protein and high fiber.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Boost Weight Loss: When to Up Mounjaro & Zepbound Dosage!In this 7:33 video from the DOWNSIZED channel, Lorraine Durham explains how she decides when to move up a dose of compounded tirzepatide, the generic name for Mounjaro and Zepbound.
GLP-1 Update - 7.5MG IS MY MAGIC DOSE!!! WEIGHTLOSS JOURNEY; ZEPBOUND/TIRZEPATIDEKeisha, who runs the channel Keeping Up with Keisha, gives an update on moving up to 7.5 mg of tirzepatide (Zepbound).
My Entire Tirzepatide GLP-1 Weight Loss Experience | 6 Months On, 6 Months Off | Mounjaro, ZepboundMadison Shari describes her experience with compounded tirzepatide, which she says is the main ingredient in Mounjaro and Zepbound.
How to Switch from Ozempic (or Wegovy) to Mounjaro | Dr. Dan | Obesity ExpertDr. Dan, who presents as an obesity expert and runs a pharmacy in Alberta, Canada, explains how he approaches switching from other GLP-1 medications to Mounjaro or Zepbound.
Mounjaro: 2.5mg vs 5mgIn this video, the creator, who goes by Mrs Hayes Loses Weight, compares her experience on Mounjaro 2.5mg with her experience after moving up to 5mg.
About Brittany Rose GLP1
Patient story, 44.3K subscribers. 27 of their videos are in GLP-1 TV, 1.1M views between them, mostly on Mounjaro, Zepbound, Wegovy.
- I’ve lost 115 lbs in a GLP1- I eat these meals on REPEAT. HIGH PROTEIN AND FIBER
- WHAT TO EXPECT MONTHS 1-3 ON A GLP1
- Mounjaro for Weight Loss week 1 | I’m SHOCKED at how much I lost!
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Mounjaro side effects: the label's numbers by dose, the low blood sugar risk, and how tirzepatide compares at weight-loss doses
On Mounjaro's own label, the common side effects are stomach ones and they rise with the dose: nausea in 12, 15 and 18 percent of people at 5, 10 and 15 mg against 4 percent on placebo, diarrhea 12 to 17 against 9, and any gastrointestinal reaction in 37 to 44 percent against 20. Most of it happens while the dose is being raised and fades. Low blood sugar is rare on Mounjaro alone and is mainly a risk when it is added to insulin or a sulfonylurea. Below: the full table, the rare warnings, and why Zepbound's numbers for the same molecule look higher.
- Mounjaro for weight loss, and why Zepbound exists
Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.
- Mounjaro vs Ozempic, and the trial everyone quotes about it
Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.
Find more like it
Side effectsDose changeWeigh-in and resultsFood, protein and eatingFood noise and cravingsConstipationLow appetite
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.